Boehringer Ingelheim — IBM antibody discovery agreement (2023)

DateDate the contract, order or partnership was announced or agreed, as stated in the cited source (YYYY-MM-DD). Empty when the source gives only a month or a year.

2023-11-281

BuyerThe purchasing organisation or named customer.

Boehringer Ingelheim1

VendorThe contracting supplier or AI provider, as named in the source.

IBM1

SectorGovernment for public-sector buyers (defence, intelligence, civil agencies, health services); Enterprise for companies.

Enterprise

Product or programThe AI product, model, platform or program supplied.

IBM foundation model technologies1

ScopeThe use case or service scope named in the source.

Therapeutic antibody discovery1

1. newsroom.ibm.com accessed 2026-11-11

Dollar figures are stated in the source’s own currency and are not converted. Read the summary for what a figure covers.